Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
clonidine (catapres) (1 trial)
ferrous sulfate (1 trial)
maltose (1 trial)
visibiome (1 trial)
Autism Spectrum Disorder (Phase 2)
Autistic Disorder (Phase 2)
Child Development Disorders, Pervasive (Phase 2)
Disease (Phase 2)
Parasomnias (Phase 2)
Sleep Initiation and Maintenance Disorders (Phase 2)
Sleep Wake Disorders (Phase 2)
Trials (3 total)
Trial APIs (4 total)